In 2007, Carpten et al. evaluated the complete coding regions of AKT family members for mutations in genomic DNA from clinical tumour specimens representing breast (n = 61), colorectal (n = 51), and ovarian (n = 50) cancers [39]. This evidence concerns the gene AKT1 and cancer.